Cancer Diagnostics Market to reach by 2040
Overview of the Cancer Diagnostics Market
Roots Analysis has published a report on the global Cancer Diagnostics market, This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.
Key Findings of the Study:
In terms of geographical regions, North America currently holds the highest atrial fibrillation treatment devices market share ( nearly 50%) .
Market Size in 2026: $9.6 Billion
Estimated Market Size in 2035: $29.0 Billion
CAGR (2026-2035): 13.1%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region
Cancer Diagnostics Adoption in the Asia Pacific Region
Request for free sample, https://www.rootsanalysis.com/reports/cancer-diagnostics-market/request-sample.html
Competitive Landscape
The Cancer Diagnostics Market has multiple key players in the market, which are profiled in the report also-
There are more key players involved in Cancer Diagnostics market mentioned in the report
Key Market Segments
Cancer Diagnostics Market Segmentation Insights
The market research report presents an in-depth analysis of the various companies that are engaged in providing consumables and instruments for cancer diagnostics across different segments, as defined in the table below:
Cancer Diagnostics Market: Report Attributes / Market Segmentations
(A complete list of key companies captured is available in the report)
The key objective of the market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for companies active in this market during the forecast period. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long-term for the period till 2032. In addition, we have segmented the future opportunity across [A] types of products (consumables and instruments), [B] types of cancer diagnostics (testing type and technology), [C] types of indication, [D] type of end users, and [E] different global regions (North America, Europe, Asia-Pacific, and the rest of the world).
To account for the uncertainties associated with the market and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base, and optimistic tracks of the market's evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market research report are in USD unless otherwise specified.
Consumables
Antibodies
Kits & Reagents
Probes
Others
Instruments
Pathology-based Instruments
Slide Staining Systems
Tissue Processing Systems
Cell Processors
PCR Instruments
NGS Instruments
Microarrays
Other Pathology-based Instruments
Imaging Instruments
CT Systems
Ultrasound Systems
MRI Systems
Mammography Systems
Nuclear Imaging Systems
Biopsy Instruments
Testing Type
Biopsy
Bone Marrow Biopsy
Endoscopic Biopsy
Fine-needle Aspiration
Liquid Biopsy
Needle Biopsy
Skin Biopsy/Punch Biopsy
Surgical Biopsy
Endoscopy
Genetic Tests
Imaging Tests
Laboratory Tests
Tumor Biomarker Tests
AFP Tests
ALK Tests
BRCA Tests
CA Tests
CEA Tests
CTC Tests
EGFR Mutation Tests
HER2 Tests
KRAS Mutation Tests
PSA Tests
Others
Technology
Flow Cytometry
Immunoassays
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarrays
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Other IVD Testing Technologies
Blood Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Melanoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Others
Diagnostic Imaging Centers
Hospitals and Clinics
Research Institutes
Diagnostic Laboratories
Others
North America
US
Canada
Mexico
Europe
Austria
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
UK
Other European countries
Asia
China
India
Japan
Singapore
South Korea
Other Asian countries
Latin America
Brazil
Chile
Colombia
Venezuela
Other Latin American countries
Middle East and North Africa Egypt
Iran
Iraq
Israel
Kuwait
Saudi Arabia
UAE
Other MENA countries
Rest of the World
Australia
New Zealand
Other countries
Abbott
Agilent
Astellas
BD
Bio-Rad
bioMérieux
Bristol-Myers Squibb
F. Hoffmann-La Roche
GE Healthcare
Genomic Health
GSK
Hologic
Illumina
Philips
Lilly
Merck
Myriad
Novartis
Pfizer
QIAGEN
Quest
Roche
R. Bard
Siemens
Thermo Fisher Scientific
Toshiba Medical Systems
Key Questions Answered in the Report-
What are cancer diagnostics?
What is the market size of cancer diagnostics?
What is the projected market size of cancer diagnostics in 2032?
What is the CAGR for cancer diagnostics market?
Which region is leading the market for cancer diagnostics?
Which indication segment is leading the market for cancer diagnostics?
What are some public cancer diagnostic companies?
To read more about key questions answered and market insights, you can refer to the full report by Roots Analysis, https://www.rootsanalysis.com/reports/cancer-diagnostics-market.html
To learn more about this report, request a free sample copy
Project ID:EX-3639-lancer
Expired
Copyright 2026 © Developed by ipoint hub, All Rights Reserved.
